其他肿瘤监测中18F-FDG PET/CT发现的垂体转移:良恶性病变SUV是否存在差异?
Pituitary Metastases Discovered by 18F-FDG PET/CT During Other Cancers Monitoring: Are There Any Differences of SUVs Between Benign and Malignant Diseases?
PubMed 文献 · Clin Nucl Med · 2021-01-01
该研究基于三级中心10347例18F-FDG PET/CT检查,发现4例(0.038%)其他肿瘤转移至垂体的病例,并报告一例46岁女性乳腺癌垂体转移。作者比较了生理性高摄取、原发肿瘤及垂体转移的SUVmax差异并与文献对比。
要点
- 18F-FDG PET/CT可偶然发现垂体病变。
- 10347例检查中垂体转移仅4例(0.038%)。
- 需鉴别生理性高摄取、原发肿瘤与垂体转移的SUVmax。
核心结论
- 18F-FDG PET/CT可发现其他肿瘤的垂体转移,但发生率低。
研究设计与样本
- 回顾性分析三级中心10347例FDG PET/CT检查,并报告一例46岁女性乳腺癌垂体转移病例。
主要发现
- 10347例FDG PET/CT检查中发现4例(0.038%)其他肿瘤的垂体转移。
关键数值与推荐
- 比较生理性高摄取、原发肿瘤及垂体转移病例的SUVmax差异,并与文献对比。
临床怎么用
- 对18F-FDG PET/CT偶然发现的垂体病变,应结合SUVmax及临床背景鉴别生理性摄取、原发肿瘤与转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
F-FDG PET/CT might discover incidental pituitary lesions. We present the case of a 46-year-old woman with breast cancer metastasis in her pituitary. We analyzed 10,347 FDG PET/CT examinations from a tertiary center, finding 4 cases (0.038%) of pituitary metastatic disease from other cancers. We analyzed the differences between SUVmax in cases of physiological high uptake, primary tumor, and hypophysis metastases from other cancers in our database compared with the literature.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Piciu A, Mester A, Piciu D, et al. Pituitary Metastases Discovered by 18F-FDG PET/CT During Other Cancers Monitoring: Are There Any Differences of SUVs Between Benign and Malignant Diseases? Clin Nucl Med. 2021. PMID: 33031239. doi:10.1097/RLU.0000000000003313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。